Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 194.45 INR
Change Today +2.15 / 1.12%
Volume 119.4K
FDCLT On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

fdc ltd (FDCLT) Snapshot

Open
193.15
Previous Close
192.30
Day High
203.50
Day Low
191.00
52 Week High
08/19/15 - 221.40
52 Week Low
09/25/14 - 138.00
Market Cap
34.6B
Average Volume 10 Days
364.7K
EPS TTM
8.33
Shares Outstanding
177.8M
EX-Date
--
P/E TM
23.3x
Dividend
2.25
Dividend Yield
1.16%
Current Stock Chart for FDC LTD (FDCLT)

Related News

No related news articles were found.

fdc ltd (FDCLT) Related Businessweek News

No Related Businessweek News Found

fdc ltd (FDCLT) Details

FDC Limited manufactures and markets various healthcare products in India and internationally. The company primarily offers therapeutics, foods, and bulk drugs. Its therapeutic products include anti fungals/dermatological, anti-anaemic, anti-diabetic, anti-haemorrhagics, anti-spasmodics, antibiotics/antibacterials, antiemetic/antinauseant, antiulcerants, antivirals, calcium supplements, cardio-vascular, central nervous system, ENT and related products, genito urinary system and sex hormones, laxatives, musculo-skeletal system, ophthalmics, orthopaedics, otologicals, pre-probiotic, respiratory and antiallergic, and stomatologicals. The company’s food products comprise anti-oxidants; balanced energy drinks; and vitamins and nutraceuticals. Its bulk drug products consist of albuterol sulfate, betaxolol hydrochloride, brimonidine tartrate, bromhexine hydrochloride, cinnarizine, dorzolamide hydrochloride, econazole nitrate, fluconazole, flunarizine dihydrochloride, flurbiprofen, flurbiprofen sodium, ketoconazole, levoalbuterol HCL, levoalbuterol sulfate/tartrate, meclizine HCL, miconazole base, miconazole nitrate, oxbutynin hydrochloride, R-flurbiprofen, salbutamol sulphate, and timolol maleate. The company also have bulk drugs under development that consist of Azelastine HCL, Brinzolamide, Duloxetine HCl, Gemifloxacine Mesylate, Latanoprost, Levo-Betaxolol HCl, Olopatadine HCl, Pregabalin, Rupatadine Fumarate, and Voriconazole. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Founded in 1936

fdc ltd (FDCLT) Top Compensated Officers

Joint Managing Director and Executive Directo...
Total Annual Compensation: 4.1M
Chairman, Managing Director, Member of Shareh...
Total Annual Compensation: 4.1M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 3.4M
Whole Time Director
Total Annual Compensation: 3.2M
Compensation as of Fiscal Year 2014.

fdc ltd (FDCLT) Key Developments

FDC Limited to Report Q1, 2016 Results on Aug 05, 2015

FDC Limited announced that they will report Q1, 2016 results on Aug 05, 2015

FDC Limited, Board Meeting, Aug 05, 2015

FDC Limited, Board Meeting, Aug 05, 2015. Agenda: To consider and approve the unaudited financial results of the company for the quarter ended June 30, 2015.

FDC Limited Announces Audited Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2015

FDC Limited announced audited earnings results for the fourth quarter and audited standalone and consolidated earnings results for the year ended March 31, 2015. For the quarter, on a standalone basis, the company reported net sales of INR 2,154.576 million compared to INR 1,971.830 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 313.065 million compared to INR 326.541 million a year ago. Profit from ordinary activities before tax was INR 450.255 million compared to INR 427.298 million a year ago. Net profit was INR 338.911 million compared to INR 17.887 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 1.91 compared to INR 0.10 a year ago. For the year, on standalone basis, the company reported net sales/income from operations of INR 8,736.060 million compared to INR 8,308.527 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,582.443 million compared to INR 1,818.415 million a year ago. Profit from ordinary activities before tax was INR 2,008.462 million compared to INR 2,169.914 million a year ago. Net profit was INR 1,459.050 million compared to INR 1,344.203 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 8.20 compared to INR 7.54 a year ago. For the year, on consolidated basis, the company reported net sales/income from operations of INR 8,852.643 million compared to INR 8,396.818 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,597.624 million compared to INR 1,821.084 million a year ago. Profit from ordinary activities before tax was INR 2,036.524 million compared to INR 2,183.625 million a year ago. Net profit was INR 1,481.454 million compared to INR 1,353.184 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 6.33 compared to INR 7.59 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FDCLT:IN 194.45 INR +2.15

FDCLT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FDCLT.
View Industry Companies
 

Industry Analysis

FDCLT

Industry Average

Valuation FDCLT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FDC LTD, please visit www.fdcindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.